Home/Filings/4/0001437749-22-019620
4//SEC Filing

Points Jeffrey S. 4

Accession 0001437749-22-019620

CIK 0001180145other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 4:23 PM ET

Size

6.2 KB

Accession

0001437749-22-019620

Insider Transaction Report

Form 4
Period: 2022-08-05
Points Jeffrey S.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-08-05+56,747184,975 total
  • Award

    Common Stock

    2022-08-05+18,916128,228 total
Footnotes (2)
  • [F1]Restrictions lapse as to 6,306 shares on 8/13/23 and as to 6,605 shares on each of 8/13/24 and 8/13/25.
  • [F2]Subject to performance-based forfeiture of 28,374 shares based on the Company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the Company's peer group, and for 28,373 shares based on the Company's average annual revenue growth in fiscal years 2023, 2024 and 2025.

Issuer

Cardiovascular Systems Inc

CIK 0001180145

Entity typeother

Related Parties

1
  • filerCIK 0001731414

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:23 PM ET
Size
6.2 KB